SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: - July 26, 2000
BIORELEASE CORP.
--------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 0-15260 88-0218411
--------------- --------------- -----------------
Jurisdiction of Commission File I. R. S. Employer
Incorporation Number Identification
Number
340 Granite Street, Suite 200, Manchester, NH 03102
---------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number:
(603) 641-8443
Item 5. Other Events
On June 30, 2000, The Company and Polar Molecular Corporation executed a further
amendment to the December 20, 1999 Amended and Restated Agreement and Plan of
Reorganization (herein referred as the "Amendment"). Under the Amendment, Polar
Molecular and the Company have agreed to extend the closing to a date not later
than September 30, 2000 in order to allow time to complete year end audits for
both companies and to complete all necessary securities filings. Under the
Amendment, Polar Molecular will continue to be responsible to reimburse the
Company for costs associated with the reorganization.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. BIORELEASE CORP
/s/ R. Bruce Reeves, President
------------------------------
R. Bruce Reeves, President
Dated: July 26, 2000
